Cancel anytime
Cellebrite DI (CLBT)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/19/2024: CLBT (5-star) is a STRONG-BUY. BUY since 130 days. Profits (73.94%). Updated daily EoD!
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Strong Buy |
Historic Profit: 89.39% | Upturn Advisory Performance 3 | Avg. Invested days: 55 |
Profits based on simulation | Stock Returns Performance 4 | Last Close 12/19/2024 |
Type: Stock | Today’s Advisory: Strong Buy |
Historic Profit: 89.39% | Avg. Invested days: 55 |
Upturn Star Rating | Stock Returns Performance 4 |
Profits based on simulation Last Close 12/19/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.57B USD |
Price to earnings Ratio - | 1Y Target Price 23 |
Dividends yield (FY) - | Basic EPS (TTM) -1.58 |
Volume (30-day avg) 1474018 | Beta 1.5 |
52 Weeks Range 7.91 - 22.63 | Updated Date 12/20/2024 |
Company Size Mid-Cap Stock | Market Capitalization 4.57B USD | Price to earnings Ratio - | 1Y Target Price 23 |
Dividends yield (FY) - | Basic EPS (TTM) -1.58 | Volume (30-day avg) 1474018 | Beta 1.5 |
52 Weeks Range 7.91 - 22.63 | Updated Date 12/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -82.28% | Operating Margin (TTM) 18.2% |
Management Effectiveness
Return on Assets (TTM) 6.35% | Return on Equity (TTM) -188.5% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 37.17 |
Enterprise Value 4215519960 | Price to Sales(TTM) 11.88 |
Enterprise Value to Revenue 10.94 | Enterprise Value to EBITDA 93.78 |
Shares Outstanding 214843008 | Shares Floating 84356510 |
Percent Insiders 46.79 | Percent Institutions 52.97 |
Trailing PE - | Forward PE 37.17 | Enterprise Value 4215519960 | Price to Sales(TTM) 11.88 |
Enterprise Value to Revenue 10.94 | Enterprise Value to EBITDA 93.78 | Shares Outstanding 214843008 | Shares Floating 84356510 |
Percent Insiders 46.79 | Percent Institutions 52.97 |
Analyst Ratings
Rating 4.75 | Target Price 9.8 | Buy 2 |
Strong Buy 6 | Hold - | Sell - |
Strong Sell - |
Rating 4.75 | Target Price 9.8 | Buy 2 | Strong Buy 6 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Cellebrite DI: A Comprehensive Overview
Company Profile:
History and Background:
- Founded in 1999, Cellebrite DI (CLBT) is an Israeli-based company specializing in digital intelligence solutions.
- Originally focused on data extraction from mobile devices for law enforcement, the company has expanded its offerings to serve various industries.
- In 2019, Cellebrite merged with Blackstone’s portfolio company, The Access Company, to become Cellebrite DI.
Core Business Areas:
- Digital Intelligence Solutions:
- Forensic Tools: Extracting data from mobile devices for law enforcement and investigations.
- Intelligence Solutions: Analyzing data to identify patterns, trends, and insights.
- Cloud Solutions: Securing and managing data in the cloud.
- Government and Enterprise Solutions:
- Serving government agencies and enterprises in sectors like finance, healthcare, and retail.
- Focuses on data privacy and compliance, cybercrime prevention, and fraud investigation.
Leadership Team and Corporate Structure:
- CEO: Yossi Carmil
- President and COO: Ron Serber
- CFO: Moshe Tzuk
- The company operates in a diversified corporate structure with subsidiaries globally.
Top Products and Market Share:
Top Products:
- UFED Series: Leading forensic toolkit for extracting data from mobile devices.
- BlackLight: Cloud-based platform for managing and analyzing digital evidence.
- Guardian: Data extraction and analysis solution for enterprises.
Market Share:
- Holds a dominant global market share in the mobile forensics market, estimated at over 60%.
- Expanding into new markets within government and enterprise segments, where market share is less established.
Product Performance and Comparison:
- UFED Series consistently praised for its data extraction capabilities and user-friendliness.
- BlackLight recognized for its scalability and cloud-based functionality.
- Competition exists from companies like Magnet Forensics and Grayshift, offering similar solutions.
Total Addressable Market:
- The global digital forensics market is estimated to be worth over $5 billion in 2023 and is projected to grow at a CAGR of over 10% through 2028.
- The enterprise segment, which Cellebrite is actively targeting, represents a significant portion of this market.
Financial Performance:
- Revenue increased by 22% year-over-year in 2022, reaching $246 million.
- Net income of $53 million in 2022, with a profit margin of 21.5%.
- EPS for 2022 was $0.44.
- Strong cash flow from operations and healthy balance sheet.
Dividends and Shareholder Returns:
- No dividend history.
- Total shareholder return of 58% over the past year.
Growth Trajectory:
- Historical growth driven by the UFED Series and law enforcement adoption.
- Future growth hinges on successful expansion into government and enterprise markets.
- Recent product launches, including Guardian, and strategic partnerships aiming to fuel growth.
Market Dynamics:
- Increasing demand for digital forensics solutions across various industries.
- Technological advancements drive innovation and competition in the market.
- Data privacy regulations and ethical concerns impact industry dynamics.
Cellebrite DI is well-positioned within the market due to its:
- Strong brand recognition and leading market share.
- Expanding product portfolio with cloud-based solutions.
- Growth through government and enterprise market penetration.
Competitors:
- Magnet Forensics (MAGT): Leading competitor in mobile forensics market.
- Grayshift: Known for GrayKey, a controversial iPhone unlocking tool.
- MSAB: Offers forensic tools and services for law enforcement.
- Other smaller players: Targeting specific market segments.
Key Challenges and Opportunities:
Challenges:
- Maintaining market leadership in the face of competition.
- Adapting to evolving technology and data privacy regulations.
- Balancing ethical considerations with market needs.
Opportunities:
- Expanding into new markets (e.g., cybersecurity, fraud detection).
- Further developing cloud-based solutions and partnerships.
- Leveraging AI and machine learning to enhance data analysis capabilities.
Recent Acquisitions:
- 2021: Acquired BlackBag Technologies, strengthening its cloud-based digital forensics offerings.
- 2021: Acquired Guardian Digital Forensics, expanding its enterprise software and solutions portfolio.
- 2022: Acquired XCellint Solutions, a specialist in mobile device acquisition and analysis.
- These acquisitions align with Cellebrite DI's growth strategy of expanding its product portfolio and entering new markets.
AI-Based Fundamental Rating:
- AI-Based Rating: 7/10
- Justification: Cellebrite DI benefits from a strong market position, robust financials, and growth potential. However, challenges from competitors and ethical considerations necessitate continuous adaptation.
Sources and Disclaimers:
- This overview utilizes data from Cellebrite DI's investor relations page, SEC filings, news articles, and market research reports.
- This information is provided for educational purposes only. It is not financial advice and should not be construed as a recommendation to invest in Cellebrite DI or any other company. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cellebrite DI
Exchange | NASDAQ | Headquaters | - |
IPO Launch date | 2021-08-31 | Founder, CEO & Director | Mr. Yossi Carmil |
Sector | Technology | Website | https://www.cellebrite.com |
Industry | Software - Infrastructure | Full time employees | 1008 |
Headquaters | - | ||
Founder, CEO & Director | Mr. Yossi Carmil | ||
Website | https://www.cellebrite.com | ||
Website | https://www.cellebrite.com | ||
Full time employees | 1008 |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.